New assay selects patients with lung cancer for treatment with immune checkpoint inhibitors

(Elsevier) A report in The Journal of Molecular Diagnostics describes a novel and rapid approach for quantifying PD-L1 expression levels in tumors that requires only small amounts of tissue that can be collected using minimally invasive bronchoscopy techniques. This approach can also be used to discriminate malignant from benign tumors and identify mutational status, all of which can guide and refine therapeutic decisions.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news